Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Farmers Insurance
AstraZeneca
Cerilliant
Julphar
Colorcon
Daiichi Sankyo
Citi
UBS
Fish and Richardson

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019972

« Back to Dashboard

NDA 019972 describes OCUPRESS, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the OCUPRESS profile page.

The generic ingredient in OCUPRESS is carteolol hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the carteolol hydrochloride profile page.
Summary for 019972
Tradename:OCUPRESS
Applicant:Novartis
Ingredient:carteolol hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019972

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength1%
Approval Date:May 23, 1990TE:RLD:Yes

Expired US Patents for NDA 019972

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis OCUPRESS carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019972-001 May 23, 1990 ➤ Subscribe ➤ Subscribe
Novartis OCUPRESS carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019972-001 May 23, 1990 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Healthtrust
Queensland Health
Cantor Fitzgerald
Daiichi Sankyo
Cerilliant
Medtronic
Teva
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot